Their use for Alcohol Use Disorder (AUD) or drug addiction is considered "off-label." However, groundbreaking clinical research from 2025 and 2026 demonstrates that these medications significantly dampen the brain's reward centers, drastically curbing cravings for alcohol, opioids, and nicotine
Adherence drops off quickly when something requires that much daily friction
Managing GI side effects well enough to stay on therapy matters beyond just weight loss
At Kalos, your journey continues after you reach your goal weightbecause we understand that significant weight loss changes your body in ways that go beyond the number you see
In laboratory settings, researchers are exploring Sema for its effects on: Cellular signaling involved in glucose regulation Hormonal interactions affecting appetite control Gastrointestinal motility models Pancreatic beta-cell function Energy expenditure pathways Neuroendocrine signaling Cardiometabolic research models In addition, Sema is frequently included in comparative studies evaluating the biological differences between various incretin-based research compounds, including newer dual receptor agonists
